rs372651860

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS1

The NM_182894.3(VSX2):​c.939T>A​(p.Ala313Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000609 in 1,583,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A313A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00050 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00062 ( 0 hom. )

Consequence

VSX2
NM_182894.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.363

Publications

0 publications found
Variant links:
Genes affected
VSX2 (HGNC:1975): (visual system homeobox 2) This gene encodes a homeobox protein originally described as a retina-specific transcription factor. Mutations in this gene are associated with microphthalmia, cataracts and iris abnormalities. [provided by RefSeq, Oct 2009]
VSX2 Gene-Disease associations (from GenCC):
  • isolated microphthalmia 2
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • microphthalmia, isolated, with coloboma 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • microphthalmia
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics
  • isolated anophthalmia-microphthalmia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • microphthalmia, isolated, with coloboma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 14-74260772-T-A is Benign according to our data. Variant chr14-74260772-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 314203.
BP7
Synonymous conserved (PhyloP=0.363 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0005 (76/152080) while in subpopulation NFE AF = 0.000633 (43/67958). AF 95% confidence interval is 0.000482. There are 0 homozygotes in GnomAd4. There are 40 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VSX2NM_182894.3 linkc.939T>A p.Ala313Ala synonymous_variant Exon 5 of 5 ENST00000261980.3 NP_878314.1 P58304

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VSX2ENST00000261980.3 linkc.939T>A p.Ala313Ala synonymous_variant Exon 5 of 5 1 NM_182894.3 ENSP00000261980.2 P58304

Frequencies

GnomAD3 genomes
AF:
0.000500
AC:
76
AN:
151962
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000633
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000600
AC:
118
AN:
196808
AF XY:
0.000491
show subpopulations
Gnomad AFR exome
AF:
0.000172
Gnomad AMR exome
AF:
0.000140
Gnomad ASJ exome
AF:
0.00512
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000579
Gnomad NFE exome
AF:
0.000730
Gnomad OTH exome
AF:
0.000586
GnomAD4 exome
AF:
0.000620
AC:
888
AN:
1431682
Hom.:
0
Cov.:
31
AF XY:
0.000584
AC XY:
414
AN XY:
709174
show subpopulations
African (AFR)
AF:
0.000212
AC:
7
AN:
32992
American (AMR)
AF:
0.000126
AC:
5
AN:
39738
Ashkenazi Jewish (ASJ)
AF:
0.00451
AC:
115
AN:
25492
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38348
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81858
European-Finnish (FIN)
AF:
0.0000980
AC:
5
AN:
51026
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5740
European-Non Finnish (NFE)
AF:
0.000652
AC:
715
AN:
1097200
Other (OTH)
AF:
0.000675
AC:
40
AN:
59288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000500
AC:
76
AN:
152080
Hom.:
0
Cov.:
33
AF XY:
0.000538
AC XY:
40
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.000145
AC:
6
AN:
41514
American (AMR)
AF:
0.000131
AC:
2
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5142
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10580
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000633
AC:
43
AN:
67958
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00108
Hom.:
0
Bravo
AF:
0.000389
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Isolated microphthalmia 2 Uncertain:1Benign:1
Mar 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Microphthalmia, isolated, with coloboma 3 Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Microphthalmia Benign:1
Apr 17, 2020
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
8.3
DANN
Benign
0.69
PhyloP100
0.36
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372651860; hg19: chr14-74727475; COSMIC: COSV56217340; API